Children with substantial externalizing symptoms who received ADHD medications had lower odds for suicidality, a cohort study showed. Researchers wrote in JAMA Network Open that “there is a critical need to identify modifiable risk and protective factors” for suicide. Previous research, they added, has shown that psychostimulants may reduce suicidal behavior in patients with ADHD, but existing studies lack information on symptom severity and other confounders.